Galena Biopharma (GALE) Posts Surprise Q4 Profit of 4c/Share

Galena Biopharma (NASDAQ: GALE) reported Q4 EPS of $0.04, $0.19 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Galena Biopharma (GALE) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Reading (RDI) Tops Q2 EPS by 4c
• Movano (MOVE) Misses Q2 EPS by 195c